{"id":1351,"date":"2023-08-24T10:10:31","date_gmt":"2023-08-24T02:10:31","guid":{"rendered":"https:\/\/celestialab.com\/?p=1351"},"modified":"2023-08-24T10:10:32","modified_gmt":"2023-08-24T02:10:32","slug":"exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis","status":"publish","type":"post","link":"https:\/\/celestialab.com\/zh\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/","title":{"rendered":"Exploring Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis"},"content":{"rendered":"<h6 class=\"wp-block-heading\">Introduction<\/h6>\n\n\n\n<p><a href=\"https:\/\/www.cdc.gov\/arthritis\/basics\/rheumatoid-arthritis.html#:~:text=Rheumatoid%20arthritis%2C%20or%20RA%2C%20is,usually%20many%20joints%20at%20once.\" target=\"_blank\" rel=\"noreferrer noopener\">Rheumatoid arthritis (RA)<\/a> is a <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4753361\/#:~:text=Chronic%20inflammatory%20systemic%20diseases%20(CIDs)%20like%20rheumatoid%20arthritis%2C%20systemic,costs%20for%20therapy%20and%20care.\" target=\"_blank\" rel=\"noreferrer noopener\">chronic systemic disease<\/a> that significantly impacts the <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK536962\/#:~:text=Quality%20of%20life%20(QoL)%20is,a%20specific%20point%20in%20time.\" target=\"_blank\" rel=\"noreferrer noopener\">quality of life<\/a>, causing damage to joints, connective tissues, muscles, tendons, and fibrous tissue. Historically, over 50% of RA patients faced disability, inability to work full-time, and elevated mortality risks.<\/p>\n\n\n\n<h6 class=\"wp-block-heading\">A Modern Alternative: Mesenchymal Stem Cell Therapy<\/h6>\n\n\n\n<p>Considering the limitations of traditional RA treatments, researchers have explored innovative approaches like <a href=\"https:\/\/celestialab.com\/zh\/\" target=\"_blank\" rel=\"noreferrer noopener\">cellular therapy<\/a> using <a href=\"https:\/\/celestialab.com\/zh\/mesenchymal-stem-cells\/\" target=\"_blank\" rel=\"noreferrer noopener\">mesenchymal stem cells (MSCs)<\/a> as a promising alternative strategy. Recent studies highlight the potential benefits of this approach in improving <a href=\"https:\/\/www.cdc.gov\/arthritis\/basics\/rheumatoid-arthritis.html#:~:text=Signs%20and%20symptoms%20of%20RA%20include%3A,both%20hands%20or%20both%20knees)\" target=\"_blank\" rel=\"noreferrer noopener\">RA patients&#8217;<\/a> lives.<\/p>\n\n\n\n<h6 class=\"wp-block-heading\">Positive Outcomes with UC-MSCs<\/h6>\n\n\n\n<p>In a groundbreaking study, Wang et al. (2010) administered intravenous UC-MSCs (1\u2009\u00d7\u200910<sup>7<\/sup> cells per kg of body weight) to 17 RA patients. The results were remarkable: patients experienced significant enhancements in diet, sleep, physical strength, and fatigue after the infusion. Moreover, liver and kidney function tests demonstrated no significant changes, and disease activity decreased.<\/p>\n\n\n\n<h6 class=\"wp-block-heading\">Promising Results from Randomized Trials<\/h6>\n\n\n\n<p>A randomized controlled trial involving 172 active RA patients, as reported by Wang et al. (2013), introduced the intravenous infusion of UC-MSCs (4\u2009\u00d7\u200910<sup>7<\/sup> cells). Over intervals of 3, 6, and 8 months, the experimental group underwent UC-MSC infusion twice. The outcomes indicated higher improvement rates in the experimental group compared to the control group.<\/p>\n\n\n\n<h6 class=\"wp-block-heading\">Sustaining the Benefits<\/h6>\n\n\n\n<p>While initial benefits to RA patients who received MSCs seemed to diminish after 3 months, subsequent observations emphasized the need for a second transplant to sustain the improvements.<\/p>\n\n\n\n<h6 class=\"wp-block-heading\">Conclusion: A Promising Option for RA Therapy<\/h6>\n\n\n\n<p>To conclude, the evidence strongly suggests that <a href=\"https:\/\/celestialab.com\/zh\/mesenchymal-stem-cells\/\" target=\"_blank\" rel=\"noreferrer noopener\">MSC<\/a>-based therapy can offer safe and effective treatment for RA. It significantly alleviates clinical symptoms and hinders disease progression. Additionally, the prospect of a second transplantation holds the potential to amplify the benefits of the initial treatment. This innovative approach marks a promising stride towards advancing the clinical therapy landscape for RA patients.<\/p>\n\n\n\n<h6 class=\"wp-block-heading\">References<\/h6>\n\n\n\n<ol class=\"wp-block-list\" type=\"1\">\n<li>Lopez-Santalla M., Bueren J.A. and Garin M.I. (2021). Mesenchymal stem\/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies<em>.&nbsp;EBioMedicine<\/em>. 69: 103427. doi:&nbsp;10.1016\/j.ebiom.2021.103427.<\/li>\n\n\n\n<li>Sarsenova M., Issabekova A., Abisheva S., Rutskaya-Moroshan K., Ogay V. and Saparov A. (2021). Mesenchymal stem cell-based therapy for rheumatoid arthritis<em>. Int J Mol Sci.<\/em> 22(21):11592. doi: 10.3390\/ijms222111592.<\/li>\n\n\n\n<li>Wang L., Cong X., Liu G., Zhou J. and Bai B. (2013). Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. <em>Stem Cells Dev<\/em>. 22: 3192-3202.<\/li>\n\n\n\n<li>Wang L.M., Zhou J.J., Bai W., Bai B., Li M. and Wang H.Y. (2010). Observation on the clinical efficacy of umbilical cord mesenchymal stem cells in the treatment of 17 patients with rheumatoid arthritis. <em>Chin J Immunol<\/em>. 26 :659-662.<\/li>\n\n\n\n<li>Wang Y., Ma D., Wu Z., Yang B., Li R., Zhao X., Yang H. and Zhang L. (2021).&nbsp;Clinical application of mesenchymal stem cells in rheumatic diseases.&nbsp;<em>Stem Cell Research and Therapy<\/em>.&nbsp;12: 567. <a href=\"https:\/\/doi.org\/10.1186\/s13287-021-02635-9\">https:\/\/doi.org\/10.1186\/s13287-021-02635-9<\/a>.<\/li>\n<\/ol>","protected":false},"excerpt":{"rendered":"<p>Introduction Rheumatoid arthritis (RA) is a chronic systemic disease that significantly impacts the quality of life, causing damage to joints, connective tissues, muscles, tendons, and fibrous tissue. Historically, over 50% of RA patients faced disability, inability to work full-time, and elevated mortality risks. A Modern Alternative: Mesenchymal Stem Cell Therapy Considering the limitations of traditional [&hellip;]<\/p>","protected":false},"author":1,"featured_media":1352,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[16],"tags":[102,100,94,87,91,95,98,58,96,92,86,93,104,101,89,88,97,103,90,99],"class_list":["post-1351","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-newsupdate","tag-alternative-strategies","tag-autoimmune-disorders","tag-cellular-therapy","tag-chronic-disease","tag-clinical-studies","tag-disease-progression","tag-healthcare-advancements","tag-immune-system","tag-innovative-treatments","tag-joint-health","tag-medical-research","tag-mesenchymal-stem-cells","tag-musculoskeletal-health","tag-patient-well-being","tag-quality-of-life","tag-ra-treatment","tag-randomized-trials","tag-regenerative-medicine","tag-rheumatoid-arthritis","tag-stem-cell-therapy"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Exploring Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis - Celestialab<\/title>\n<meta name=\"description\" content=\"Rheumatoid arthritis (RA) is a chronic systemic disease that significantly impacts the quality of life, causing damage to joints, connective tissues, muscles, tendons, and fibrous tissue. Historically, over 50% of RA patients faced disability, inability to work full-time, and elevated mortality risks.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celestialab.com\/zh\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exploring Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis - Celestialab\" \/>\n<meta property=\"og:description\" content=\"Rheumatoid arthritis (RA) is a chronic systemic disease that significantly impacts the quality of life, causing damage to joints, connective tissues, muscles, tendons, and fibrous tissue. Historically, over 50% of RA patients faced disability, inability to work full-time, and elevated mortality risks.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celestialab.com\/zh\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/\" \/>\n<meta property=\"og:site_name\" content=\"Celestialab\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CelestiaLab\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-24T02:10:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-24T02:10:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/celestialab.com\/wp-content\/uploads\/2023\/08\/Exploring-Mesenchymal-Stem-Cell-Therapy.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"william\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"william\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/\"},\"author\":{\"name\":\"william\",\"@id\":\"https:\/\/celestialab.com\/#\/schema\/person\/f073d002746d000667c3e2734e7d2d79\"},\"headline\":\"Exploring Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis\",\"datePublished\":\"2023-08-24T02:10:31+00:00\",\"dateModified\":\"2023-08-24T02:10:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/\"},\"wordCount\":470,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/celestialab.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/celestialab.com\/wp-content\/uploads\/2023\/08\/Exploring-Mesenchymal-Stem-Cell-Therapy.jpg\",\"keywords\":[\"Alternative strategies\",\"Autoimmune disorders\",\"Cellular therapy\",\"Chronic disease\",\"Clinical studies\",\"Disease progression\",\"Healthcare advancements\",\"Immune System\",\"Innovative treatments\",\"Joint health\",\"Medical research\",\"Mesenchymal stem cells\",\"Musculoskeletal health\",\"Patient well-being\",\"Quality of life\",\"RA treatment\",\"Randomized trials\",\"Regenerative medicine\",\"Rheumatoid arthritis\",\"Stem cell therapy\"],\"articleSection\":[\"news&amp;update\"],\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/\",\"url\":\"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/\",\"name\":\"Exploring Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis - Celestialab\",\"isPartOf\":{\"@id\":\"https:\/\/celestialab.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/celestialab.com\/wp-content\/uploads\/2023\/08\/Exploring-Mesenchymal-Stem-Cell-Therapy.jpg\",\"datePublished\":\"2023-08-24T02:10:31+00:00\",\"dateModified\":\"2023-08-24T02:10:32+00:00\",\"description\":\"Rheumatoid arthritis (RA) is a chronic systemic disease that significantly impacts the quality of life, causing damage to joints, connective tissues, muscles, tendons, and fibrous tissue. Historically, over 50% of RA patients faced disability, inability to work full-time, and elevated mortality risks.\",\"breadcrumb\":{\"@id\":\"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/#primaryimage\",\"url\":\"https:\/\/celestialab.com\/wp-content\/uploads\/2023\/08\/Exploring-Mesenchymal-Stem-Cell-Therapy.jpg\",\"contentUrl\":\"https:\/\/celestialab.com\/wp-content\/uploads\/2023\/08\/Exploring-Mesenchymal-Stem-Cell-Therapy.jpg\",\"width\":1000,\"height\":1000},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/celestialab.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exploring Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/celestialab.com\/#website\",\"url\":\"https:\/\/celestialab.com\/\",\"name\":\"CelestiaLab\",\"description\":\"New Chapter for a Revitalized Humanity\",\"publisher\":{\"@id\":\"https:\/\/celestialab.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/celestialab.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/celestialab.com\/#organization\",\"name\":\"CelestiaLab\",\"url\":\"https:\/\/celestialab.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/celestialab.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/celestialab.com\/wp-content\/uploads\/2020\/06\/outlineCelestialab-01.png\",\"contentUrl\":\"https:\/\/celestialab.com\/wp-content\/uploads\/2020\/06\/outlineCelestialab-01.png\",\"width\":2560,\"height\":1383,\"caption\":\"CelestiaLab\"},\"image\":{\"@id\":\"https:\/\/celestialab.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/CelestiaLab\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/celestialab.com\/#\/schema\/person\/f073d002746d000667c3e2734e7d2d79\",\"name\":\"william\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/celestialab.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/81008889bb0aaa0c27d4fd311b2f44cb08e2bdf560799c9ffa32bd71503ec3de?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/81008889bb0aaa0c27d4fd311b2f44cb08e2bdf560799c9ffa32bd71503ec3de?s=96&d=mm&r=g\",\"caption\":\"william\"},\"sameAs\":[\"http:\/\/staging.celestialab.com\"],\"url\":\"https:\/\/celestialab.com\/zh\/author\/william\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exploring Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis - Celestialab","description":"Rheumatoid arthritis (RA) is a chronic systemic disease that significantly impacts the quality of life, causing damage to joints, connective tissues, muscles, tendons, and fibrous tissue. Historically, over 50% of RA patients faced disability, inability to work full-time, and elevated mortality risks.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celestialab.com\/zh\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/","og_locale":"zh_CN","og_type":"article","og_title":"Exploring Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis - Celestialab","og_description":"Rheumatoid arthritis (RA) is a chronic systemic disease that significantly impacts the quality of life, causing damage to joints, connective tissues, muscles, tendons, and fibrous tissue. Historically, over 50% of RA patients faced disability, inability to work full-time, and elevated mortality risks.","og_url":"https:\/\/celestialab.com\/zh\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/","og_site_name":"Celestialab","article_publisher":"https:\/\/www.facebook.com\/CelestiaLab\/","article_published_time":"2023-08-24T02:10:31+00:00","article_modified_time":"2023-08-24T02:10:32+00:00","og_image":[{"width":1000,"height":1000,"url":"https:\/\/celestialab.com\/wp-content\/uploads\/2023\/08\/Exploring-Mesenchymal-Stem-Cell-Therapy.jpg","type":"image\/jpeg"}],"author":"william","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"william","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"3 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/#article","isPartOf":{"@id":"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/"},"author":{"name":"william","@id":"https:\/\/celestialab.com\/#\/schema\/person\/f073d002746d000667c3e2734e7d2d79"},"headline":"Exploring Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis","datePublished":"2023-08-24T02:10:31+00:00","dateModified":"2023-08-24T02:10:32+00:00","mainEntityOfPage":{"@id":"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/"},"wordCount":470,"commentCount":0,"publisher":{"@id":"https:\/\/celestialab.com\/#organization"},"image":{"@id":"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/#primaryimage"},"thumbnailUrl":"https:\/\/celestialab.com\/wp-content\/uploads\/2023\/08\/Exploring-Mesenchymal-Stem-Cell-Therapy.jpg","keywords":["Alternative strategies","Autoimmune disorders","Cellular therapy","Chronic disease","Clinical studies","Disease progression","Healthcare advancements","Immune System","Innovative treatments","Joint health","Medical research","Mesenchymal stem cells","Musculoskeletal health","Patient well-being","Quality of life","RA treatment","Randomized trials","Regenerative medicine","Rheumatoid arthritis","Stem cell therapy"],"articleSection":["news&amp;update"],"inLanguage":"zh-Hans","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/","url":"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/","name":"Exploring Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis - Celestialab","isPartOf":{"@id":"https:\/\/celestialab.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/#primaryimage"},"image":{"@id":"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/#primaryimage"},"thumbnailUrl":"https:\/\/celestialab.com\/wp-content\/uploads\/2023\/08\/Exploring-Mesenchymal-Stem-Cell-Therapy.jpg","datePublished":"2023-08-24T02:10:31+00:00","dateModified":"2023-08-24T02:10:32+00:00","description":"Rheumatoid arthritis (RA) is a chronic systemic disease that significantly impacts the quality of life, causing damage to joints, connective tissues, muscles, tendons, and fibrous tissue. Historically, over 50% of RA patients faced disability, inability to work full-time, and elevated mortality risks.","breadcrumb":{"@id":"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/#primaryimage","url":"https:\/\/celestialab.com\/wp-content\/uploads\/2023\/08\/Exploring-Mesenchymal-Stem-Cell-Therapy.jpg","contentUrl":"https:\/\/celestialab.com\/wp-content\/uploads\/2023\/08\/Exploring-Mesenchymal-Stem-Cell-Therapy.jpg","width":1000,"height":1000},{"@type":"BreadcrumbList","@id":"https:\/\/celestialab.com\/2023\/08\/24\/exploring-mesenchymal-stem-cell-therapy-for-rheumatoid-arthritis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celestialab.com\/"},{"@type":"ListItem","position":2,"name":"Exploring Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis"}]},{"@type":"WebSite","@id":"https:\/\/celestialab.com\/#website","url":"https:\/\/celestialab.com\/","name":"CelestiaLab","description":"\u673a\u4f53\u6062\u590d\u5065\u5eb7\u6d3b\u529b\u7684\u65b0\u7bc7\u7ae0","publisher":{"@id":"https:\/\/celestialab.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celestialab.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/celestialab.com\/#organization","name":"CelestiaLab","url":"https:\/\/celestialab.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/celestialab.com\/#\/schema\/logo\/image\/","url":"https:\/\/celestialab.com\/wp-content\/uploads\/2020\/06\/outlineCelestialab-01.png","contentUrl":"https:\/\/celestialab.com\/wp-content\/uploads\/2020\/06\/outlineCelestialab-01.png","width":2560,"height":1383,"caption":"CelestiaLab"},"image":{"@id":"https:\/\/celestialab.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CelestiaLab\/"]},{"@type":"Person","@id":"https:\/\/celestialab.com\/#\/schema\/person\/f073d002746d000667c3e2734e7d2d79","name":"william","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/celestialab.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/81008889bb0aaa0c27d4fd311b2f44cb08e2bdf560799c9ffa32bd71503ec3de?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/81008889bb0aaa0c27d4fd311b2f44cb08e2bdf560799c9ffa32bd71503ec3de?s=96&d=mm&r=g","caption":"william"},"sameAs":["http:\/\/staging.celestialab.com"],"url":"https:\/\/celestialab.com\/zh\/author\/william\/"}]}},"_links":{"self":[{"href":"https:\/\/celestialab.com\/zh\/wp-json\/wp\/v2\/posts\/1351","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celestialab.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celestialab.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celestialab.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/celestialab.com\/zh\/wp-json\/wp\/v2\/comments?post=1351"}],"version-history":[{"count":0,"href":"https:\/\/celestialab.com\/zh\/wp-json\/wp\/v2\/posts\/1351\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/celestialab.com\/zh\/wp-json\/wp\/v2\/media\/1352"}],"wp:attachment":[{"href":"https:\/\/celestialab.com\/zh\/wp-json\/wp\/v2\/media?parent=1351"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celestialab.com\/zh\/wp-json\/wp\/v2\/categories?post=1351"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celestialab.com\/zh\/wp-json\/wp\/v2\/tags?post=1351"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}